Seer (SEER) Common Equity (2020 - 2026)
Seer (SEER) recorded quarterly Common Equity of $241.5 million in Q1 2026, down 6.88% quarter-over-quarter from $259.3 million in Q4 2025, and down 22.36% on a YoY basis from $311.0 million in Q1 2025.
Seer (SEER) Common Equity (2020 - 2026) Analysis & Trends
Seer's Common Equity history runs 7 years deep, the most recent figure standing at $241.5 million for Q1 2026.
- In Q1 2026, Common Equity fell 22.36% year-over-year to $241.5 million; the TTM figure through Mar 2026 stood at $241.5 million (down 22.36% YoY), while the FY2025 annual figure was $259.3 million, down 20.84% from the prior year.
- Common Equity was $241.5 million for Q1 2026 at Seer, down from $259.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $486.5 million in Q1 2022 to a low of $241.5 million in Q1 2026.
- Historically, Common Equity has averaged $371.1 million across 5 years, with a median of $383.6 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Common Equity slipped 9.2% in 2022, then retreated 22.36% in 2026.
- A 5-year view of Common Equity shows it stood at $447.0 million in 2022, then slipped by 11.21% to $396.9 million in 2023, then fell by 17.47% to $327.6 million in 2024, then dropped by 20.84% to $259.3 million in 2025, then slipped by 6.88% to $241.5 million in 2026.
- The last three Common Equity figures came in at $241.5 million (Q1 2026), $259.3 million (Q4 2025), and $271.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 241.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.48 Mn |
| Dec 31, 2025 | 259.31 Mn |
| Sep 30, 2025 | 271.81 Mn |
| Jun 30, 2025 | 288.29 Mn |
| Mar 31, 2025 | 311.01 Mn |
| Dec 31, 2024 | 327.57 Mn |
| Sep 30, 2024 | 344.73 Mn |
| Jun 30, 2024 | 364.70 Mn |
| Mar 31, 2024 | 383.56 Mn |
| Dec 31, 2023 | 396.90 Mn |
| Sep 30, 2023 | 405.68 Mn |
| Jun 30, 2023 | 418.12 Mn |
| Mar 31, 2023 | 432.99 Mn |
| Dec 31, 2022 | 446.99 Mn |
| Sep 30, 2022 | 457.77 Mn |
| Jun 30, 2022 | 472.04 Mn |
| Mar 31, 2022 | 486.46 Mn |
| Dec 31, 2021 | 502.92 Mn |
| Sep 30, 2021 | 515.20 Mn |
| Jun 30, 2021 | 526.04 Mn |